2 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Daclizumab or Basiliximab: new trials by email Literature Review of Daclizumab or Basiliximab trials Research Report on Daclizumab or Basiliximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Islet After Kidney Transplantation Islet transplantation, Antithymocyte Globulin, Daclizumab or Basiliximab - Type 1 Diabetes Mellitus | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 24 | 2007-01-01 | 2017-10-20 |
| Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte globulin - Diabetes Mellitus, Type 1 | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 14 | 2006-10-01 | 2016-03-16 |
Diabetes Mellitus, Type 1 (2) · Hypoglycemia (2)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2) · Canada (1)
Andrew Posselt, MD, PhD (1) · Bernhard Hering, MD (1) · James F. Markmann, MD, PhD (1) · Xunrong Luo, MD, PhD (1)